000 01360 a2200349 4500
005 20250515035902.0
264 0 _c20060928
008 200609s 0 0 eng d
022 _a0002-9149
024 7 _a10.1016/j.amjcard.2005.12.025
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aNambi, Vijay
245 0 0 _aCombination therapy with statins and omega-3 fatty acids.
_h[electronic resource]
260 _bThe American journal of cardiology
_cAug 2006
300 _a34i-38i p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAnti-Inflammatory Agents
_xtherapeutic use
650 0 4 _aCholesterol, HDL
_xdrug effects
650 0 4 _aCholesterol, LDL
_xdrug effects
650 0 4 _aCombined Modality Therapy
650 0 4 _aDyslipidemias
_xdiet therapy
650 0 4 _aFatty Acids, Omega-3
_xtherapeutic use
650 0 4 _aFibrinolytic Agents
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aHydroxymethylglutaryl-CoA Reductase Inhibitors
_xtherapeutic use
650 0 4 _aMyocardial Infarction
_xdiet therapy
650 0 4 _aPractice Guidelines as Topic
650 0 4 _aTriglycerides
_xmetabolism
700 1 _aBallantyne, Christie M
773 0 _tThe American journal of cardiology
_gvol. 98
_gno. 4A
_gp. 34i-38i
856 4 0 _uhttps://doi.org/10.1016/j.amjcard.2005.12.025
_zAvailable from publisher's website
999 _c16506021
_d16506021